Statistics

Total Visits

Views
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer(legacy) 152
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer(legacy) 67

Total Visits per Month

December 2022 January 2023 February 2023 March 2023 April 2023 May 2023 June 2023
Randomized, double-blind, placebo-controlled phase II study of AMG 386 combined with weekly paclitaxel in patients with recurrent ovarian cancer 0 1 2 1 0 1 0

File Downloads

Views

Top Country Views

Views
United States 60
Netherlands 29
China 20
Germany 18
Australia 17
France 5
Bangladesh 2
Ireland 2
Vietnam 2

Top City Views

Views
Rotterdam 29
Ashburn 24
Beijing 12
Fairfield 12
Kaleen 12
Cambridge 6
Dallas 2
Dhaka 2
Hanoi 2
Tettnang Castle 2